These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25641783)

  • 1. The beta-cell in type 1 diabetes: What have we learned from proteomic studies?
    Crèvecoeur I; Rondas D; Mathieu C; Overbergh L
    Proteomics Clin Appl; 2015 Aug; 9(7-8):755-66. PubMed ID: 25641783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding type 1 diabetes through proteomics.
    Crèvecoeur I; Vig S; Mathieu C; Overbergh L
    Expert Rev Proteomics; 2017 Jul; 14(7):571-580. PubMed ID: 28649880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
    Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
    Front Immunol; 2021; 12():667989. PubMed ID: 33953728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes.
    van Lummel M; Zaldumbide A; Roep BO
    Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):299-306. PubMed ID: 23770733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise increases pancreatic β-cell viability in a model of type 1 diabetes through IL-6 signaling.
    Paula FM; Leite NC; Vanzela EC; Kurauti MA; Freitas-Dias R; Carneiro EM; Boschero AC; Zoppi CC
    FASEB J; 2015 May; 29(5):1805-16. PubMed ID: 25609426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta cell immunopeptidome.
    Dudek NL; Purcell AW
    Vitam Horm; 2014; 95():115-44. PubMed ID: 24559916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life and death of β cells in Type 1 diabetes: A comprehensive review.
    Wilcox NS; Rui J; Hebrok M; Herold KC
    J Autoimmun; 2016 Jul; 71():51-8. PubMed ID: 27017348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells.
    Gurgul-Convey E
    Cells; 2020 Aug; 9(8):. PubMed ID: 32759843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes.
    Massa O; Alessio M; Russo L; Nardo G; Bonetto V; Bertuzzi F; Paladini A; Iafusco D; Patera P; Federici G; Not T; Tiberti C; Bonfanti R; Barbetti F
    J Proteomics; 2013 Apr; 82():263-73. PubMed ID: 23500132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Hormone-Negative Endocrine Cells in the Pancreas in Type 1 Diabetes.
    Md Moin AS; Dhawan S; Shieh C; Butler PC; Cory M; Butler AE
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3487-96. PubMed ID: 27300574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles of β-cell mass and function during type 1 diabetes onset and remission.
    Chmelova H; Cohrs CM; Chouinard JA; Petzold C; Kuhn M; Chen C; Roeder I; Kretschmer K; Speier S
    Diabetes; 2015 Jun; 64(6):2148-60. PubMed ID: 25605805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation.
    Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K
    Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
    Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
    Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proteomic study of the regulatory role for STAT-1 in cytokine-induced beta-cell death.
    Rondas D; Gudmundsdottir V; D'Hertog W; Crèvecoeur I; Waelkens E; Brunak S; Mathieu C; Overbergh L
    Proteomics Clin Appl; 2015 Oct; 9(9-10):938-52. PubMed ID: 25712914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes.
    Nakayasu ES; Qian WJ; Evans-Molina C; Mirmira RG; Eizirik DL; Metz TO
    Expert Rev Proteomics; 2019 Jul; 16(7):569-582. PubMed ID: 31232620
    [No Abstract]   [Full Text] [Related]  

  • 17. Pancreatic Beta Cell Survival and Signaling Pathways: Effects of Type 1 Diabetes-Associated Genetic Variants.
    Santin I; Dos Santos RS; Eizirik DL
    Methods Mol Biol; 2016; 1433():21-54. PubMed ID: 26936771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in type 1 diabetes: new research progress and potential directions.
    Miao C; Chang J; Zhang G; Fang Y
    Biochem Cell Biol; 2018 Oct; 96(5):498-506. PubMed ID: 29554441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An accomplice more than a mere victim: The impact of β-cell ER stress on type 1 diabetes pathogenesis.
    Sahin GS; Lee H; Engin F
    Mol Metab; 2021 Dec; 54():101365. PubMed ID: 34728341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic Reticulum-Mitochondria Crosstalk and Beta-Cell Destruction in Type 1 Diabetes.
    Vig S; Lambooij JM; Zaldumbide A; Guigas B
    Front Immunol; 2021; 12():669492. PubMed ID: 33936111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.